United States Biotechnology & Medical Research

Theseus Pharmaceuticals Inc (THRX)

Track

Track

Ticker: THRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Theseus Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
84.98
Quantity 46,288 -13.1%
Value US$1,285,106
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
67.62
Quantity 61,800 -37.1%
Value US$291,623
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
243.40
Quantity 17,039 -27.6%
Value US$684,383
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.05
Quantity 328,482 +2.0%
Value US$1,001,870
3.7
HAYDEN DONALD J JR Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 9,900 +9900.0%
Value US$49,489
3.7
HAYDEN DONALD J JR Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 100 +inf%
Value US$500
2.4
Dahms Bradford D. Chief Financial Officer Officer
Transaction date
Planned purchase
Price
6.66
Quantity 1,502 +32.4%
Value US$10,000
3.1
CLACKSON TIMOTHY P President and CEO Executive Director
Transaction date
Purchase
Price
6.80
Quantity 2,500 +0.7%
Value US$16,995
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.21
Quantity 192,000 +1.2%
Value US$1,000,320
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.21
Quantity 192,000 +1.2%
Value US$1,000,320
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.97
Quantity 111,896 +0.7%
Value US$1,115,603
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.97
Quantity 111,896 +0.7%
Value US$1,115,603
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.95
Quantity 35,000 +0.2%
Value US$348,250
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.95
Quantity 35,000 +0.2%
Value US$348,250
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.97
Quantity 11,521 +0.1%
Value US$114,864
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.97
Quantity 11,521 +0.1%
Value US$114,864
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.43
Quantity 17,320 +0.1%
Value US$163,328
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.43
Quantity 17,320 +0.1%
Value US$163,328
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.06
Quantity 18,897 +0.1%
Value US$190,104
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.06
Quantity 18,897 +0.1%
Value US$190,104
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.67
Quantity 6,900 +0.0%
Value US$73,623
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.81
Quantity 1,600 +0.0%
Value US$15,696
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.67
Quantity 6,900 +0.0%
Value US$73,623
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.81
Quantity 1,600 +0.0%
Value US$15,696
3.1
CLACKSON TIMOTHY P President and CEO Executive Director
Transaction date
Purchase
Price
9.76
Quantity 2,600 +0.8%
Value US$25,381
2.4
Dahms Bradford D. Chief Financial Officer Officer
Transaction date
Purchase
Price
10.15
Quantity 1,970 +inf%
Value US$20,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 62,500 +14.3%
Value US$1,000,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 562,500 +3.6%
Value US$9,000,000
1.4
Shakespeare William See Remarks Officer
Transaction date
Purchase
Price
16.00
Quantity 625 +0.2%
Value US$10,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 62,500 +14.3%
Value US$1,000,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 562,500 +3.6%
Value US$9,000,000
3.3
Omega Fund VI, L.P. Former 10% owner
Transaction date
Purchase
Price
16.00
Quantity 187,500 +35.8%
Value US$3,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-19 2023-07-17 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
46,288 -13.1%
84.98
US$1,285,106 		46,288 -13.1% 84.98 US$1,285,106
2023-07-19 2023-07-17 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
61,800 -37.1%
67.62
US$291,623 		61,800 -37.1% 67.62 US$291,623
2023-07-19 2023-07-17 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
17,039 -27.6%
243.40
US$684,383 		17,039 -27.6% 243.40 US$684,383
2023-07-19 2023-07-17 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
328,482 +2.0%
3.05
US$1,001,870 		328,482 +2.0% 3.05 US$1,001,870
2023-07-19 2023-07-17 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
176,550 +14.6%
2.97
US$524,354 		176,550 +14.6% 2.97 US$524,354
2023-07-19 2023-07-17 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
523,450 +14.6%
2.97
US$1,554,646 		523,450 +14.6% 2.97 US$1,554,646
2023-01-03 2022-12-30 B Purchase
3.7
HAYDEN DONALD J JR
Non-Executive Director
9,900 +9900.0%
5.00
US$49,489 		9,900 +9900.0% 5.00 US$49,489
2023-01-03 2022-12-29 B Purchase
3.7
HAYDEN DONALD J JR
Non-Executive Director
100 +inf%
5.00
US$500 		100 +inf% 5.00 US$500
2023-01-03 2022-12-29 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
250,000 +26.1%
5.00
US$1,250,000 		250,000 +26.1% 5.00 US$1,250,000
2023-01-03 2022-12-29 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
250,000 +7.5%
5.00
US$1,250,000 		250,000 +7.5% 5.00 US$1,250,000
2022-12-01 2022-11-30 PP Planned purchase
2.4
Dahms Bradford D.

Chief Financial Officer

Officer
1,502 +32.4%
6.66
US$10,000 		1,502 +32.4% 6.66 US$10,000
2022-11-14 2022-11-11 B Purchase
3.1
CLACKSON TIMOTHY P

President and CEO

Executive Director
2,500 +0.7%
6.80
US$16,995 		2,500 +0.7% 6.80 US$16,995
2022-11-09 2022-11-07 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
192,000 +1.2%
5.21
US$1,000,320 		192,000 +1.2% 5.21 US$1,000,320
2022-11-09 2022-11-07 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
192,000 +1.2%
5.21
US$1,000,320 		192,000 +1.2% 5.21 US$1,000,320
2022-01-21 2022-01-21 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
111,896 +0.7%
9.97
US$1,115,603 		111,896 +0.7% 9.97 US$1,115,603
2022-01-21 2022-01-21 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
111,896 +0.7%
9.97
US$1,115,603 		111,896 +0.7% 9.97 US$1,115,603
2022-01-21 2022-01-20 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
35,000 +0.2%
9.95
US$348,250 		35,000 +0.2% 9.95 US$348,250
2022-01-21 2022-01-20 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
35,000 +0.2%
9.95
US$348,250 		35,000 +0.2% 9.95 US$348,250
2022-01-21 2022-01-19 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
11,521 +0.1%
9.97
US$114,864 		11,521 +0.1% 9.97 US$114,864
2022-01-21 2022-01-19 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
11,521 +0.1%
9.97
US$114,864 		11,521 +0.1% 9.97 US$114,864
2022-01-13 2022-01-13 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
17,320 +0.1%
9.43
US$163,328 		17,320 +0.1% 9.43 US$163,328
2022-01-13 2022-01-13 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
17,320 +0.1%
9.43
US$163,328 		17,320 +0.1% 9.43 US$163,328
2022-01-13 2022-01-12 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
18,897 +0.1%
10.06
US$190,104 		18,897 +0.1% 10.06 US$190,104
2022-01-13 2022-01-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
18,897 +0.1%
10.06
US$190,104 		18,897 +0.1% 10.06 US$190,104
2022-01-13 2022-01-11 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
6,900 +0.0%
10.67
US$73,623 		6,900 +0.0% 10.67 US$73,623
2022-01-13 2022-01-11 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,600 +0.0%
9.81
US$15,696 		1,600 +0.0% 9.81 US$15,696
2022-01-13 2022-01-11 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
6,900 +0.0%
10.67
US$73,623 		6,900 +0.0% 10.67 US$73,623
2022-01-13 2022-01-11 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,600 +0.0%
9.81
US$15,696 		1,600 +0.0% 9.81 US$15,696
2021-12-22 2021-12-21 B Purchase
3.1
CLACKSON TIMOTHY P

President and CEO

Executive Director
2,600 +0.8%
9.76
US$25,381 		2,600 +0.8% 9.76 US$25,381
2021-12-22 2021-12-21 B Purchase
2.4
Dahms Bradford D.

Chief Financial Officer

Officer
1,970 +inf%
10.15
US$20,000 		1,970 +inf% 10.15 US$20,000
2021-10-14 2021-10-12 B Purchase
2.8
Rock Springs Capital Management LP
Large shareholder
250,000 +71.6%
16.00
US$4,000,000 		250,000 +71.6% 16.00 US$4,000,000
2021-10-14 2021-10-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
62,500 +14.3%
16.00
US$1,000,000 		62,500 +14.3% 16.00 US$1,000,000
2021-10-14 2021-10-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
562,500 +3.6%
16.00
US$9,000,000 		562,500 +3.6% 16.00 US$9,000,000
2021-10-14 2021-10-12 B Purchase
1.4
Shakespeare William

See Remarks

Officer
625 +0.2%
16.00
US$10,000 		625 +0.2% 16.00 US$10,000
2021-10-14 2021-10-12 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
62,500 +14.3%
16.00
US$1,000,000 		62,500 +14.3% 16.00 US$1,000,000
2021-10-14 2021-10-12 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
562,500 +3.6%
16.00
US$9,000,000 		562,500 +3.6% 16.00 US$9,000,000
2021-10-14 2021-10-12 B Purchase
3.3
Omega Fund VI, L.P.

Former 10% owner
187,500 +35.8%
16.00
US$3,000,000 		187,500 +35.8% 16.00 US$3,000,000
Explore more

More insider trading research around Theseus Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America